A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD9567.

Trial Identifier: D6470C00001
Sponsor: AstraZeneca
NCTID:: NCT02512575
Start Date: November 2015
Primary Completion Date: September 2016
Study Completion Date: September 2016
Condition: Healthy Volunteers; Other; Rheumatoid Arthritis

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations